Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

NCT00069186 is registered in ClinicalTrials.gov with The Avicena Group as lead sponsor.

NCT NCT00069186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00069186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Lead sponsor
The Avicena Group
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2003
Completion date
April 30, 2005
Enrollment
107
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als)